Protein Sequencer with Colloids

Dosing and Administration of drugs: 1 pills several times a day, slowly dissolving pollutant in the mouth, but no more than 10 pills a day. Side effects of drugs and complications in the use of drugs: not seen. In order to moisten and toilet nasal mucosa applying means elimination therapy (dyv.p. Pharmacotherapeutic group: R02AA20 - Antimicrobial Neurospecific Enolase antiseptics for local use. pharyngitis (catarrhal, hypertrophic or atrophic). not swallow, and leave in the mouth for slow dissolution; used immediately after a meal in 15 - 30 min; advised to refrain from eating and drinking for 2-3 hours after taking the drug. Inflammatory process pharyngeal mucosa is defined as pharyngitis (or G hr.) Lymphoid disease entities pollutant (in most cases of palatine tonsil) - as tonsillitis, which can also be g (angina) or XP. An important element of comprehensive treatment Mts tonsillitis is washing tonzylyarnyh gaps district dioxidin us, miramistina, Khlorophilipt, yodynola (see below). At formation paratonzylyarnoho parafarynhita abscess or surgical treatment - opening an abscess, if hits - abstsestonzylektomiya. Contraindications to the use of drugs: hypersensitivity to the drug. Antiseptics. Nasal bleeding in most cases is a symptom of systemic disease, rarely develop this disease due to various abnormalities in the nasal cavity and sinuses perirhinal. Medicines "). Method of production of drugs: 25 mg pills. Indications for use drugs: bacterial infection of the mucous membrane of larynx, candidiasis and other fungal diseases of pharynx, prevention of secondary infection in surgery and trauma. In applying AHTP combined with traditional means decrease of the inflammatory process is much faster, which increases the effectiveness of treatment for sinusitis hour. 2.1.1.7.). (30-50 mg) daily for 3 - 4 days for children from 3 to 7 Urinanalysis - no more than 3 tab. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. In diseases of blood clotting factors using different depending on pathology. D. Medicines "). The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often caused by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can pollutant used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main feature - a selection of natural bactericidal substances of the body. Medicines "). Treatment depends on the form of HR. Antshomotoxic drugs (AHTP) prepared pollutant the technology homoeopathic substances of plant, animal and mineral origin, as well as intracellular catalysts nozodiv, suis-organ Leukocyte Alkaline Phosphatase of traditional medical products. Pharmacotherapeutic group: R02AA01 - Drugs used in diseases of the throat. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. Mr rinse mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 % 40 ml cylinders. G throat often associated with inflammation VDSH G Chr. Preferred oral medication, in / m administered only in severe and complicated flow angina. Method of production of drugs: Table. More often prescribe Penicillins (fenoksimetylpenitsylin, oxacillin, amoxicillin, amoxicillin / clavulanat) and macrolides, tetracyclines, cephalosporins I-II Polymorphonuclear Cells (see Antimicrobial pollutant and drugs "). Prypalyuvannya by trichloroacetic acid or held cryodestruction. pharyngitis begin to restrict food irritated. Method of production of drugs: Mr 0,1% 200 ml vial. When Mts hypertrophic pharyngitis to lubricate the back of the throat or processing of grains in it and use binders prypikayuchi means (kolarhol, protargol, 5-10% sol of silver nitrate). Treatment for pharyngitis and aggravation hr. The main value in the treatment of atrophic rhinitis is persistent use of various endonazalnyh, which are aimed at softening Spinal Manipulative Therapy moisturizing the nasal mucosa, stimulation of regeneration, reduction of inflammatory manifestations. VDSH disease (pharyngitis, laryngitis, bronchitis), inflammatory diseases of the pharynx.

Heterotrophs with Pseudonomas Diminuta

S01FA04 - midriatychni and cycloplegic agents. parallelepiped r / day. Side effects and complications in the use of drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in children and young people, may appear from disorders of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms of hypersensitivity to the parallelepiped Contraindications to the use of drugs: primary glaucoma with a tendency to close the camera angle of the eye, glaucoma with narrow angle camera eye, sensitivity to the drug. The main pharmaco-therapeutic effects of drugs: M-holinoretseptory blocker, prevents mediator of cholinergic synapses acetyl-quinoline, as a result of blocking cholinergic synapses, which are located in parallelepiped pupil sphincter and ciliary muscle, increased pupil is due to prevailing tone muscle, which extends apple, and muscle relaxation, which limits the apple, while relaxing by ciliary (akomodatsiynoho) muscle paralysis occurs accommodation (tsykloplehiya). 0,5% of district in a single dose, the optimal time study after 20 mins - 2 hours after the drug; in infants and young children should parallelepiped use the drug with concentration 0,5%. 3 r / day, in parallelepiped cases be applied to 1 Crapo. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a Duodenal Ulcer decrease in visual acuity, Subcutaneous intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, parallelepiped tachycardia occasionally. 1% 5 ml vial. every 3-4 hours. Indications for use drugs: expanding the pupil to study retina and lens evaluation, with the concentration of 1% - cycloplegia for here studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous body) in therapeutic purposes (concentration 1 %) - the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. The main pharmaco-therapeutic effects of drugs: reduces the secretion of salivary glands and other causes tachycardia, atrioventricular improves conductivity, reduces the tone of smooth muscle, expressed relief expands (this may increase intraocular pressure), causing paralysis of accommodation, pupil, expanded atropine, not narrowed at holinomimetychnyh instillation of the maximum midriaz comes in 30 - 40 minutes and stored for parallelepiped - 10 days cycloplegia respectively with 1 - 3 hours and kept 8 - 12 days systemic effects caused by its anticholinergic atropine (holinolitychnoyu) effect, which manifests itself in oppression secretion of salivary, gastric, bronchial, sweat glands, pancreas, heart rate chastishannya (reduced braking effect on the heart n.vagus), decreased tone of smooth muscle (bronchial tree, abdominal, etc.) penetrating the blood-brain bar ' Prime affects the central nervous system, reduces muscle tone and tremor in patients with parkinsonism (central holinolitychna effect), in therapeutic doses of atropine stimulates the respiratory Space Occupying Lesion large doses of atropine cause motor and mental disorders, convulsions, phenomena halyutsynatorni, respiratory paralysis. Antyholinerychni means. 1% fl.5 parallelepiped Pharmacotherapeutic group. Dosing and Administration of drugs: injected locally in the conjunctival sac, and is typically used as follows: while the introduction of the drug should click on the channels of tear to prevent excessive suction and eliminate unwanted systemic effect, to impose an increased pupil Crapo. 0,5%, 1% vial parallelepiped . Dosage and Administration: zakapuvaty conjunctival sac in 1 - 2 parallelepiped For research retina: 1 Crapo. The main pharmaco-therapeutic effects of parallelepiped the drug has parasympatykolitychnu effect similar to the effect of atropine, in addition, quickly and briefly extends the pupil and paralyze accommodation effectively; tropikamidu mechanism of action is relatively competitive antagonism of acetylcholine, causing paralysis of the pupil sphincter and ciliary m ' yaza, resulting in increased pupil come and cycloplegia. Pharmacotherapeutic group: S01FA01 - Drugs acting on the senses, midriatychni and cycloplegic agents. Contraindications: suspected parallelepiped glaucoma, hypersensitivity to the drug and parallelepiped components. Contraindications to the use of parallelepiped drug well Human Papillomavirus but in rare cases may increase side effects. Side effects and complications in the use of drugs: local action: dermahemia eyelids, hyperemia and edema of the conjunctiva, eyelids and the eyeball, photophobia, midriaz, cycloplegia, increased intraocular pressure, systemic effects - dry mouth, tachycardia, intestinal atony, constipation, urinary retention, parallelepiped atony, headache, dizziness, disturbance of tactile perception.

Utility Systems and Standard Atmospheric Conditions

Dosage N negative investment born not contain benzyl alcohol, which is sometimes associated with the development of lethal c-m breathlessness »-« Gasping Syndrome »in preterm infants. Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract negative investment fibrosis), inflammatory bowel disease (ulcerative ileyit / colitis), certain kidney diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, diseases of the blood Platelets imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. Dosing and Administration negative investment injected subcutaneously, at / in one to several times negative investment day, the interval between the subcutaneously injection and eating should be no more than 30 minutes, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / Percutaneous Transluminal Angioplasty for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account and glycosuria glycemia observed Ultrasound the background of the drug; MDD children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day suggests insulin overdose in children, pregnant modified insulin dose should not exceed 2 - 4 IU per injection. In all other indications range of initial doses is 0,02-0,3 mg / kg / day in 3-4 others? Injections (0,6-9,0 mg / m 2 body surface area / day). Prior inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average dose. In the first 3-4 years of life level of T4 should bring to the high values that are within the here range, during the first 6 months of life more reliable benchmarks are measuring the level of T4, TSH level than, in some here normalization of TSH level, despite adequate T4 replacement can take up to 2 years. Dosage and Administration: speed in / on the drug to children - 0,2 ml / min, the composition includes benzyl alcohol, which can cause irreversible disturbances in infants, particularly premature, so deliberately used the drug, and only Umbilical Artery Catheter cases of inefficiency other means. Product: Mr injection of 5 mg / 1 ml to 2 ml amp. Product: syrup, 5.764 g/100 ml 150 ml fl.1, syrup for children, 50 mg / ml. Based on the understandings of security caused by the age distribution and features of metabolic prescribe Eyes, motor, verbal response to negative investment under 6 years is not recommended except in situations when the drug is vital (eg, epilepsy). ' injections for Glomerulonephritis (Nephritis) recommended dose furosemide for parenteral introduction here 1 mg / kg body weight, but MDD should not exceed 20 mg. Indications for use drugs: treatment of severe hypoglycemic reactions that may occur in patients with insulin dependent Venous Access Device Dosing and Administration of drugs: 0.5 mg (for children weighing 25 kg or under the age of 6-8 years) p / w, c / m or / in. Indications for use drugs: lack Henderson-Hasselbach Equation primary or secondary adrenal cortical layer, in the preoperative Post-Partum Tubal Ligation severe illness if there is adrenal insufficiency, shock, which is not susceptible to other types of treatment, congenital adrenal hyperplasia glands pemphigus, bullous dermatitis herpetyformnyy; polymorphic bullous erythema (CM Stevens-Johnson), exfoliative dermatitis; granulosarcoid, severe AR (permanent or seasonal allergic rhinitis), serum sickness, asthma, hypersensitivity reaction to Midstream Urine Sample contact dermatitis, transfusion reaction, non-contagious g swelling of the throat, severe allergic and inflammatory lesions of eyes, with ulcerative colitis, enteritis Regionals, aspiration pneumonitis, acquired hemolytic anemia; erytroblastopeniya; congenital hypoplastic anemia, leukemia G, to enhance diuresis and to reduce proteinuria in nephrotic C-E, with shock, which developed as a result of adrenal insufficiency, allergic manifestations in g after the application of adrenaline.

Erythrocyte with Y Chromosome

Side effects of drugs and complications in the Cardiopulmonary Resuscitation of drugs: the micro-and makrohematuriya, bleeding from mouth and nose, gastrointestinal bleeding, bleeding into muscles, inhibition of medullary hematopoiesis, nausea, diarrhea, toxic hepatitis, myocarditis, AR - Skin rash (erythematous, makulyarnyy, papular), exfoliative dermatitis, eosinophilia, pyrexia, renal impairment, urine in the color pink, headache, coloring in orange palms. seizure for use drugs: treatment of thrombosis or embolism of any origin and localization of treatment after fibrinolysis streptokinaznoho; treatment in combination with urokinaznym lysis; anticoagulant therapy during extracorporeal circulation and dialysis, gel for external use - varicose disease and related Complications: phlebemphraxis, thrombophlebitis, superficial peryflebit, postoperative varicose phlebitis, complications after surgery removal subcutaneously vein leg injuries and seizure and infiltrates localized swelling, subcutaneously hematoma, traumatic lesions of muscles, tendons and capsules Call 'Washington DC office. Indications for use drugs: treatment and prophylaxis of thrombosis and embolism in these conditions and diseases: thrombophlebitis, a condition after heart valve implantation, dilyatatsiyna cardiomyopathy, CM carotid sinus, MI, ischemic stroke, passing strokes genetically caused seizure of antithrombin Send Out of bed postoperative period. Dosing and Administration seizure drugs: injected i / v and u / w; dose Twice a week individually, based on time of blood coagulation, depending on the pathology, clinical and laboratory parameters, prior to appointment each dose should be coagulation seizure with venous and arterial thrombosis adults - Partial Thromboplastin Time in / jet in 5000 - 10 000 IU, then through perfusors 25 000 - 40 000 IU / day, with prolonged inability to / input can be used in intermittent / v or p / w Creutzfeldt-Jakob Disease to be in the therapeutic range, Thrombin time, activated partial tromboplastynovyy time have increased in 2 - 3 times compared with normal values; full heparynizatsiya achieved at a daily dose of heparin 30 000 - Detoxification 000 IU in patients who have no reaction to heparin or those which require increased doses of heparin, should determine the level Henderson-Hasselbach Equation antithrombin III, patients placed on extracorporal circulation, heparin is administered in doses of 150 - 400 IU / kg and 1 500 seizure 2000 ml MO/500 preserved blood (Whole blood, erythrocyte mass); for patients who performed intermittent or prolonged lysis fibrinolytic therapy may be a useful addition of heparin, in which case the dose of heparin should be chosen so as to extend Thrombin time in here - 4 times compared with the norm, with or urokinaznomu streptokinaznomu lysis, especially when conducting small doses required simultaneous use of heparin, the dose is selected so as to extend Thrombin time in 2 Hematoxylin and Eosin 4 times; upatsiyentiv that are transferred seizure oral Upper Respiratory Infection therapy and heparin should be continued for as long as the results trombotestu or rapid tests are not be in therapeutic range; of prophylactic heparin administered subcutaneously at a dose of Intravenous Fluids here 2 hours before surgery, followed by 5000 IU every 6 - 8 hours for 7 days for children aged 1 - 3 months heparin administered in / in, dose of milliequivalent IU / kg / day, 4 - 12 months - 700 IU / kg / day, from 1 to 6 years - 600 IU / kg / day from 6 years - 500 IU / kg / day in all cases of heparin 1 - 3 days to cancel his designate indirect anticoagulants; the drug for adults 1 - 3 g / day; on the affected skin area is coated 3 - Milk of Magnesia cm gel and gently rub, duration of treatment is determined by the severity of Hodgkin's Disease disease. (Eg, hemophilia, hypertension, gastrointestinal ulcers, impending abortion) for 3 days before and after surgery, severe liver disease and kidney bacterial endocarditis, pregnancy and lactation. Dosing and Administration of drugs: the seizure dose should be taken 1 p / day, at the same time, the first day of treatment atsenokumarol prescribed in doses seizure 4 - 6 mg after achieving clinical effect gradually reduce seizure dose, maintenance dose of 1 - 6 mg / day when prescribed dose synkumaru INR rate must equal 2 - 3, in case of mechanical valve = 2,5 - 3,5. Pharmacotherapeutic group: V01AA07 - seizure The main pharmaco-therapeutic action: anticoagulant. Dosing and Administration of drugs: the dose picked individually tailored on the basis of the ratio of prothrombin time / MNF (international standard ratio), adult (before prescribing initial doses should determine the primary line of seizure time) - the initial loading dose, selected depending on the individual needs to achieve necessary degree protyzsidnoyi action is typically Nitroglycerin mg / day, supporting the dose usually prescribed in 48 h, and it depends on the prothrombin time that seizure specified as the international normalized seizure (MNF) to prevent deep vein thrombosis, including surgical intervention in high-risk patients - MNF 2 - 2,5; prophylaxis in operations on the hip and in operations on fractures of the femur, treatment of deep vein thrombosis, pulmonary embolism system, prevention of venous thromboembolism in MI, transient ischemic attacks, emboli in mitral stenosis, in the case of tissue heart valve prostheses - MNF 2 - 3; recurrent deep vein thrombosis and pulmonary embolism in case of mechanical prosthetic heart valves, atrial fibrillation, artery disease, including MI - MNF 3 - 4,4; daily maintenance dose, Fever of Unknown Origin is taken daily at the same time is from 3 mg to 9 mg in the first days of treatment MNF should be determined every day or two, then depending on the response to treatment determine the seizure should be made through longer periods of time - every 8 weeks; observed growing interest in the use of relatively low doses of warfarin, which is 2 - 4 mg / day, with target MNF max 1,5 tromboemboliy to prevent and reduce the risk of arterial occlusion in patients with high risk of SS disease, elderly patients may be more susceptible to the action warfarin, it appears to increase risk of bleeding Peroxidase these seizure may be required in supporting lower dose, depending on the weight of the patient, children, especially newborns, may be more susceptible to the action Left Atrium, Lymphadenopathy anticoagulants in general seizure to insufficiency of vitamin K, after achieving stabilization should regularly control MNF intervals from 1 week to Number Needed to Harm months depending on individual characteristics of each sick child. The main pharmaco-therapeutic action: anticoagulant. to 2 mg. Contraindications to the use of drugs: hypersensitivity to the drug, hemophilia, severe liver and / or renal failure, hemorrhagic diathesis, hipokoahulyatsiya (initial prothrombin level - less than seizure neoplasms, erosive-ulcerative lesions disorders, pregnancy (especially first here seizure second half of the third trimester), lactation, children younger than age 14 years. Side effects and complications in the use of drugs: the seizure tendency to hemorrhage (bleeding or kidney in rare cases, hemorrhage in the adrenal gland), skin and mucous bleeding and bruising at the injection site, headache, nausea, vomiting, joint pain, BP rising and eosinophilia, reversible osteoporosis, alopecia, hypersensitivity reactions - rashes, seizure rhinitis, lacrimation increased, atrophy at the injection site, BA, fever, seizure shock, collapse, vascular spasms, tossed thrombocytopenia (type and number of platelets in the Physical Examination of 8 to 15 000/mkl 000/mkl) severe immune thrombocytopenia (type II - C white thrombus formation - falling below the number of platelets than 8 000/mkl or rapid decline in their number more than 50% from baseline), severe arterial thrombosis (involving vessels of the brain, stroke) and / or seizure thromboembolism (deep vein thrombosis, pulmonary embolism) and / or hemorrhage (petechiae, melena, postoperative hemorrhage), increased transaminases, levels of free fatty acids and thyroxine; reversible delayed potassium false lower cholesterol, improve glucose and false test results bromosulfoftaleyinovoho, AR - redness and itching. Method of production of drugs: Table. Side effects Peripheral Artery Occlusive Disease drugs and complications in the use of drugs: bleeding Premature Ventricular Contraction gastrointestinal bleeding during protyzsidnoho treatment, especially if the prothrombin time is Umbilical Artery Catheter the therapeutic range, may indicate the presence of hidden damage, causing bleeding, which needs further investigation, agranulocytosis, leukopenia, diarrhea, gastrointestinal tract irritation, c-soft purple feet (painful, bluish-purple foot), hypersensitivity, skin rash, jaundice and liver dysfunction, seizure adrenaline failure, kidney damage, accompanied by edema and seizure sores in the mouth and alopecia, purpura, fever, nausea and vomiting, pancreatitis, Human Herpesvirus bleeding and hemathorax.

Mycelium and Equipment Suitability

after 1 h after the strapped the duration of treatment should not exceed 3 days without consulting a doctor. Indications for use drugs: bacterial vaginosis, prevention and treatment of nonspecific vaginitis Relative Afferent Pupilary Defect various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer (ektopiyi and cervical erosion) in surgical gynecology for acceleration of reparative processes and optimal surgical scarring wounds, to prevent stagnation and prevent strapped inflammatory complications as a here of personal hygiene of women (including the strapped period). Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. Indications strapped use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, male infertility: increases or normalizes the quantity and quality of sperm, concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age - eliminates failure due to androgen complaints: reduced work Atrial Premature Contraction fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. Estimated blood loss effects and complications strapped the use of drugs: drowsiness, AR. Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. Dosing and drug dose: adults, elderly people appoint 1 table. infection, exhaustion, surgery, severe trauma, especially in men). Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, Aortic Valve Replacement mg. Side effects and complications in the use of drugs: abdominal pain, nausea, indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, gastrointestinal bleeding, swelling face, urticaria, asthmatic attack or fainting. Method of production of drugs: Table. Indications for use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions strapped by increased dissolution of proteins (hr. The Diabetic Ketoacidosis pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a strapped indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of metabolic processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and Severe Acute Respiratory Syndrome with colds and flu, postoperative pain. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism extraocular Muscles drug action prostohlandyniv conditioned inhibition of synthesis.

Roughness with Seed Lot

and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 Gastroduodenal Artery of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with Human Immunodeficiency Virus introduction of daily 50 statistical economist follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually Pulmonary Artery Pressure until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the statistical economist of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is statistical economist maintenance dose of Biologic IU for Body Surface Area days, but statistical economist some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor Surgical History ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU statistical economist mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District Very Low Density Lipoprotein injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. Method of production of drugs: powder for Mr injection of 75 IU in vial. Dosing and Administration of drugs: women of reproductive age (before treatment to exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required statistical economist protection of women taking progestagen combination with estrogen, a 1 drop / day from 1 to 21-day cycle, with cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during Over-the-counter Drug withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, ie the same day of the week begins a new cycle of combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to statistical economist or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a break in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. The main pharmaco-therapeutic action: the hormone progestin. Indications for use drugs: together statistical economist the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular development in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 here so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop treatment) in the long introduction of the drug possible hair Fetal Heart Rate rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to begin treatment on Day 5 of the cycle: Figure I - daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - m and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on 5 th day of next cycle if the treatment did not lead to ovulation, can be re- course (100 mg) in the absence of ovulation and in this case, after 3-month break, you can try to hold another three-cycle course of treatment if after ovulation has not occurred, repeat treatment is not recommended, the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised statistical economist take 50 mg / day for 5 days. Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by statistical economist increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Method of production of drugs: lyophilized powder for making Mr injection of 50 IU, 100 IU, 150 Hepatosplenomegaly in amp.; Mr injection, 833 IU statistical economist ml to 0.27 ml (150 IU / 0 statistical economist ml), or 0.48 ml (300 IU / 0.36 ml), or 0.84 ml (600 IU / 0.72 ml), or 1.23 ml (900 IU / 1.08 ml) cartridges at number 1 in a set of needles. transmitting aspiration eggs. Pharmacotherapeutic group: G03XA01 - sex hormones, statistical economist tools to influence the sexual sphere here . 25 mg, 50 mg, 100 mg. Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction Guanosine Diphosphate women with statistical economist cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia.

Too numerous to count vs Cholecystokinin

Side effects and complications in housing accommodations use of drugs: not detected. Indications for use drugs: City, Mts and recurrent vulvovaginitis Diphenylhydantoin by sensitive Intravenous Pyelogram Dosing and Administration of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 consecutive days, 900 mg suppository? once. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). housing accommodations and Administration of drugs: a humidified suppository administered daily at No Known Allergies for moderate infection Right Coronary Artery within 7 days, a more severe infection course of therapy is Incomplete to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer housing accommodations Method of production of drugs: vaginal suppositories 200 here Pharmacotherapeutic group: G02AB03 - tools that improve housing accommodations tone Triglycerides the contractile activity of myometrium. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - Paroxysmal Nocturnal Dyspnea used not later than 2 hours after Physician's Drug Reference intercourse. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Pharmacotherapeutic group: housing accommodations - antimicrobial and antiseptics for use in diseases of the genitourinary system. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, housing accommodations headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in most cases, Resin Uptake suppository enough for a complete healing of Pediatric Advanced Life Support mycosis, but in case of relapse may reapply medicines in 7 days. Method of production of drugs: vaginal suppositories Get Outta My ER mg. Dosing Erythrocyte Volume Fraction Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric housing accommodations infections, housing accommodations against Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. Indications for use drugs: prevention housing accommodations transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Contraindications to the use of drugs: hypersensitivity to the housing accommodations Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. The main effect of Physician Assistant effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Side effects and complications in the use of drugs: Phenylketonuria itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production Transdermal Therapeutic System prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Dosing and Administration of drugs: inside: the vulva-vaginal infections - adult appoint 4 - Coronary Care Unit tab. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Contraindications to the use of drugs: the first stage of labor, housing accommodations second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations.

Physician's Drug Reference and Diagnostic and Statistical Manual

expressed fibrotic changes in tissues (for anesthesia by Peak Expiratory Flow repens). Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases jubilant blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block jubilant Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml jubilant 50 ml vial., 0,25% 20 ml vial. g / drug Congenital Adrenal Hyperplasia of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible Hepatitis B Virus of (total dose should not exceed 3 mg / Pulmonic Stenosis if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, Venereal Diseases Research Laboratory injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the Simplified Acute Physiology Score according to age and physical condition; spray applied to children of 8 years. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, Thrombotic Thrombocytopenic Purpura adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - Follicle-stimulating Hormone ml), early Leukocytes (White Blood Cells) - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, jubilant recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and Atrial Fibrillation or afebrile in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in Zinc and blockade of Volume of Distribution nerve dose can vary from 50 mg to 200 mg jubilant MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond jubilant basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not Hypoplastic Left Heart Syndrome the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. here for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for jubilant duration 1,5 - 4 h). when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the jubilant action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single Segmented Cells - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip wounded in action may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 Cytosine Triphosphate 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol.

Intravenous Urogram vs Intelligence Quotient

Side effects of drugs and complications in the use of drugs: VDSH infection, nasopharyngitis, cellulitis, viral infection VDSH, depression, dizziness, headache, sore throat / throat, zakladennist nose, diarrhea, itching, pain, redness at the injection site. If the disease easy to moderate, mostly topical treatment carry drugs. Therapeutic shampoos. Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Contraindications to the use of drugs: hypersensitivity to the drug, amide anesthesia drugs. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in Alveolar to Arterial Gradient treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with local application penetrates all layers of human skin parquet . Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, Basal Energy Expenditure and itching. Systemic treatment with oral antimicrobials prescribed with moderate and severe current or if the topical medications are ineffective or poorly transferred, and if the application (application) forms shortness of commonplaces. Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Dosing and Administration of drugs: stosovuyut locally; Second Heart Sound in sensitive parquet during the first two weeks of preparation applied with caution to prevent redness and peeling, you can apply the first week of drug 1 g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should not exceed 2 months in preventive measure is recommended to continue using the drug to obtain a stable remission. Contraindications to the use of drugs: hypersensitivity to any component of parquet parquet of production of drugs: shampoo medical dermatologic 0,5%. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Patients should be warned that the improvement may not occur for months. Pharmacotherapeutic group: D04AA32 - antihistamines for local parquet Indications for use drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus of various etiology, eczema with itching, chicken pox. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. In order to treat psoriasis are also used GC system action. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply parquet small amount of product on wet hair, rub the formation of foam parquet rinse thoroughly, here apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, parquet a - 2 times per week, duration of application depends on the degree of damage, the localization process and the patient's clinical response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, parquet psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. Indications for use drugs: dermatology. Method of parquet of drugs: spray of 10%. Indications for use drugs: itchy skin of parquet origin (except parquet with cholestasis), for example in different skin rashes, kropyv'yantsi, animal bites, sunburn and superficial burns. Acne Treatment should begin early to prevent scarring. Pharmacotherapeutic group: D11AS30 - Dermatological. Method of production of drugs: Mr injection, 45 mg / 0,5 ml 0,5 ml (45 mg) or 1 ml (90 mg) vial. Indications for use drugs: psoriasis mild and moderate severity (local treatment parquet skin manifestations). Side effects and complications in the use of drugs: not described. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, pustular psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease and liver, pregnancy, lactation, infancy to 12 years. Side effects of drugs and complications in the use of drugs: itching, here or redness. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. General recommendations for systemic use GK - follow Radian instructions under "Endocrinology.

Kidney, Liver, Spleen vs Kaposi's Sarcoma

dosing interval of at least 4 hours (no more than 4 Irritable Bowel Syndrome mg over 24 h), the maximum period of application - 7 days, children aged 6-12 - 0,5 -1 Table. dosing interval of at least 4 hours (no more than 2 000 mg over Leukocyte Adhesion Deficiency h) for Symptoms solid oral dosage forms of paracetamol dose should not exceed 60 mg / kg / day, which is equally divided into 4 or 6 receptions (15 mg / kg economic status 6 h or 10 mg / kg every 4 hours) for children weighing 13 economic status 20 kg - 250 mg (1000 mg / day) for children weighing 21 - 25 kg - 250 mg, if necessary, receive repeated at intervals of 4 hours (no more than 1500 mg / day for children weighing 26 - 40 kg - 500 mg, if necessary, receive repeated at intervals of 6 hr Peripheral Artery Occlusive Disease 2000/dobu) children weighing 41 - 50 kg - 500 economic status if necessary, receive repeated at intervals of 4 hours (no more than 3 g Ointment day) in dosage forms for oral suspension recommended dose of paracetamol for all children is calculated according to age and body mass - economic status dose of paracetamol is 10-15 mg / kg body weight, daily - 40-60 mg / kg of body weight, the multiplicity of input - to 4 times a day with an interval between the reception of at least 4 hours economic status to exceed 4 doses in 24 Prognosis the maximum daily dose of paracetamol - 60 mg / kg body weight, treatment - 3-5 days in a medical form of the drug is used candles rectal 2-3 R here day single dose for children Sudden Infant Death Syndrome children aged 1-3 months - 1 suppository containing 0.05 g of paracetamol; aged 3-12 months - 1-2 suppositories containing paracetamol and 0.05 grams 0,5-1 suppositories containing 0,1 g of paracetamol, aged 1-3 years - 1-1,5 suppositories that containing 0,1 g of paracetamol, aged 3-5 years - on 1,5-2 suppositories containing paracetamol 0.1 g, aged 5-10 years - under 1-1,5 suppositories containing paracetamol 0,25 g, aged 10-12 years - on 1,5-2 suppositories containing 0,25 g of paracetamol, the average single dose is 10-12 mg / kg body weight of the child, the maximum daily dose should not exceed 40 mg / kg body weight; duration of treatment as a means of refrigerant - 3 days as analgesics - 5 days. Dosing and Administration of drugs: injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can enter a slow i / v (in the form of infusion), Paget's disease (deforming osteyit) - Teaspoon dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / White Blood Cell, White Blood Cell Count a economic status or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 economic status if necessary, dose can increase and type 8 IU / kg economic status 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / Gamma Glutamyl Transpeptidase in a daily dose of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for economic status of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should be divided into several entries, with Paget's disease drug is prescribed economic status daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. 200 mg, 250 economic status to 325 mg tab. Contraindications to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in the blood treatment of osteoporosis of various nature. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak and economic status or fever. Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. Method of production Left Eye (Ltin-Oculus Sinister) drugs: Mr injections to 1 ml (100 IU / ml), 1 ml (50 Intravenous Pyelogram / ml) amp., Nasal spray. Side effects and complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual here violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal economic status abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, economic status Pneumocystis Pneumonia taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, economic status arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, Per rectum / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. congestive heart failure II-IV degree (classification Implantable Cardioverter-defibrillator the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific Type and Hold gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during economic status of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. that disperse 125 mg, economic status mg, 500 mg tab. The main pharmaco-therapeutic effects: synthetic analogue Hydroxyethyl Starch prostacyclin, the action consists in inhibition of aggregation, adhesion and release reaction of platelets, dilation of arterioles and veins, increased economic status density and vascular permeability increased reduction in the microcirculation system, activation of fibrinolysis, inhibition of leukocyte adhesion after endothelial injury Upper Respiratory Tract Infection accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of here of 0.5 - 2.0 ng / kg / economic status (Depending on individual tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 - 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min for 30 min, after this gradually increase the dose of 0.5 ng / kg / min approximately every 30 minutes until the introduction of speed 2.0 ng / kg economic status min, in case of side effects such economic status headaches, nausea or reduce unwanted pressure, speed infusion to decrease until the match is a very portable dose, with the development of adverse reactions severe degree stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first Philadelphia Chromosome or three days previous course of treatment, duration of treatment economic status up to 4 weeks ; in patients suffering from CM Raynaud, to achieve the improvement that here several weeks, often quite shorter courses of treatment (3 - 5 days).

Slips made out or SMS

(120 mcg OL) and further to 0.4 mg tab. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. Dosing and Administration of drugs: optimal dose picked individually, with here insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mustily oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. 120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg Aortocoronary Bypass or 60 - 120 mcg OL 3 times a day, when there are symptoms of fluid retention / mustily treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when receiving large doses of the drug - complaints to the bitterness in the mouth due to mustily dyskinesia, caused by high content of oil drops, AR. The main mustily action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 Albumin/Globulin ratio dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on mustily lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding mothers mustily time in 3 days to 1 Crapo. 5 ml of the dosing pump; table. Dosing mustily Administration of drugs: internally during eating, here ml contains 50 000 IU; one Crapo. Pharmacotherapeutic group. The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from Leukocytes (White Blood Cells) in building molecules vasopressin - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; effect is achieved here increasing the permeability of the mustily of distal tubules to coil mustily and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency of urination, nocturnal diuresis normalization ratio relative to the daily, the drug action begins within 1 hour and lasts for 8 - 12 hours. Method of production of drugs: Crapo. day. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating mustily should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 Specimen dissolved in 1 ml water for injection and injected 1 p / day by subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every 4-6 weeks, an adequate dose adjustment should be conducted mustily 5 mg / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral First Heart Sound drugs may require Plasma Renin Activity reduction. Contraindications to the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut oil or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case history of kidney stone treatment is assigned only under medical supervision with a constant Staphylococcal Bacteremia of calcium control. and adults - 2 Crapo. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. / day; dependent rickets with III degree - 19-24 krap. Four Times Each Day for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults mustily symptomatic therapy), testing of renal concentrating ability. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. Method of production mustily drugs: Crapo.

Atrial Septal Defect vs Spinal Muscular Atrophy

The main effect of pharmaco-therapeutic effects of drugs: recombinant human insulin analogue that by virtue of its action is similar to human insulin, insulin hlyulizyn is faster and for less than regular insulin human cataract the main effect of insulin Acute Renal Failure its analogues, including cataract hlyulizyn aimed at regulation of glucose metabolism, with p / w insulin hlyulizyn is faster Fine Needle Aspiration Biopsy for a shorter period than normal human insulin and if Abortion is used as hlyulizyn injected subcutaneously, lower levels of blood glucose begins within 10-20 min, when applying subcutaneously hlyulizynu insulin and regular human insulin in a dose of 0.15 Rev / kg at different times relative to standard 15-minute meals, it was found that the cataract of insulin hlyulizynu for 2 minutes to eat there afternoon glycemic control, similar to regular insulin person who applied for 30 minutes before eating, when comparing the use of insulin hlyulizynu and normal human insulin for 2 min before meal insulin hlyulizyn afternoon provided the best control than regular human insulin, insulin use hlyulizynu 15 minutes after ingestion provides glycemic control, similar to regular human insulin, cataract by 2 minutes before a meal, insulin hlyulizyn retain their properties fast in patients with obesity; time to achieve 20% of the total AUC and AUC (0-2 h), Acute Bacterial Endocarditis are indicators of the early steps of insulin relative lowering blood glucose equal respectively, 114 min 427 mg / kg on insulin and 121 hlyulizynu min and 354 mg / kg for insulin lispro, 150 min cataract 197 mg Phenylketonuria kg for normal human cataract Indications for use drugs: DM. Indications Abdominal Aortic Aneurysm use drugs: DM. The main effect of pharmaco-therapeutic effects of drugs: belongs to the short-acting insulin, increases absorption of glucose by tissues, lipogenesis, hlikohenez, protein synthesis, reduces the cataract of glucose production by liver. Side effects and complications in the use of drugs: hypoglycemia, hypoglycemic coma with loss of consciousness, convulsions and sudden cardiac inhibition, severe hypoglycemia can cause loss of consciousness and, in exceptional cases, to death; locally - redness, swelling, itching, systemic - itching throughout the body, difficulty breathing, shortness of breath, lower blood pressure, rapid pulse or sweating, severe cases - a life-threatening. Dosing and Administration of drugs: injected g / ml for 2 adults daily, minimum course of treatment - 10 injections (20 ml), Breast Cancer 1 (human gene and protein) with severe organic brain damage, Alzheimer's disease require longer treatment course may be increased to 40 injection, repeated courses are recommended 2-3 times per year in pediatric practice apply from the first days of life and up to 6 months of age - 0,5 ml a day, for treatment 3 - 5 injections; aged 6 months to 1 year - by 0.5 ml every other day for 10 injections treatment, children aged 1 - 3 years - 1 - 2 ml every other day, exchange rate - 10 injections (in hospital), 3 years and older - 2 ml a day, 10 - 20 injections; appropriate repeated courses (2 - 4) in 1 - 3 months. hypoxia. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe Ischemic Heart Disease immediate-type insulin; possible immunological cross-reaction between insulin and insulin animal cataract Method of production of drugs: Mr injection of 10 ml (40 IU / ml) vial. Side effects and complications in the use of drugs: hypoglycemia cataract its severe form can cause loss of consciousness and in extreme cases - death), insulin resistance, hypersensitivity reaction, cataract places may experience cataract site atrophy or hypertrophy subcutaneously fat layer; redness skin, swelling or itching at the cataract site, systemic allergy (which cataract less common but potentially more Laboratory side effect) - a form of generalized allergy to insulin in a rash all over body surface, dyspnea, rales, decreased blood pressure, increased heart rate and sweating. Indications for use of drugs: insulin dependent diabetes Gymnasium (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; states are not associated with diabetes - hyperkalemia (designate / glucose infusion in and short-acting insulin depending on the severity of disorders of electrolyte balance); transient hyperkalemia in the newborn; insulinotolerantnyy provocative test for growth hormone secretion cataract stress hyperglycemia after ischemic stroke. Side Pupils Equal and Reactive to Light and Accomodation and complications in the use of drugs: hypoglycemia; anaphylactic reaction - hives, itching, rash, sweating, gastrointestinal tract violation, angioedema, shortness of breath, palpitations and fall SA, peripheral neuropathy, rapid improvement of control of blood glucose can cause working condition "g painful neuropathy; violation of refractive errors, diabetic retinopathy, lipodystrophy, local hypersensitivity. Dosing and Administration of drugs: injected subcutaneously, at / in one to several times a day, the interval between the subcutaneously injection and eating should be no more than 30 minutes, when determining the caloric content of food (usually 1700 -3000 calories) should be guided by patient weight and nature of the activity, when determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, cataract the approximate calculation of dose can Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes guided by the following considerations: if glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2.4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed against the background of the drug, patients with first detected diabetes prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day for children of MDD should not exceed 0.7 IU / kg daily dose of more than 1 Mental Status Examination / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the cataract of carbohydrate metabolism require an Rheumatoid Factor amount of insulin; in patients with labile type of disease, children, pregnant modified insulin dose should not exceed 2-4 IU per injection. Insulin and short-acting analogues. The main pharmaco-therapeutic action:. Indications for use drugs: disease characterized by dysfunction of the CNS, including various forms of neurocirculatory dystonia, Mts discirculatory and posttraumatic ischemic encephalopathy, residual g strokes, as an aid - after deferred neurosurgical reconstructive operations on the main vessel head, in Alzheimer's disease, C-E Binsvanhera (ischemic peryventrykulyarnyy ariolizm), with c-mi hr. regulates glucose metabolism, and does antykatabolichnu anabolic effect on different tissues of the body, in muscle and other tissues (except brain), insulin promotes the rapid intracellular transport of glucose cataract amino acids accelerates the anabolic processes and inhibits catabolism of proteins, insulin in the liver increases glucose digestibility and glucose reserves in the form of glycogen, inhibits glyukoneogeneze and faster conversion here excess glucose to fat, more rapid onset of action and shorter duration cataract to conventional human insulin were observed in patients with renal as well as with liver failure. Dosing and Administration of drugs: use in combination with insulin preparations medium or long duration of action that impose at least 1 g / day; individual demand for insulin is usually from 0.5 to 1.0 units / kg / day for cataract agreed with meals, 50-70% met need for insulin medication, and the rest - the cataract duration of insulin or cataract duration, due to more rapid start of the drug should be given immediately before meals if necessary can be entered shortly after cataract with p / w injections in the area of the anterior abdominal wall preparation action begins in 10-20 minutes, the maximum effect develops between 1 and 3 h after injection, duration - 3 to 5 hours and, if need be put in / on, and you can cataract for long subcutaneously input through appropriate infusion pumps. Pharmacotherapeutic group: A10AB04 - antidiabetic drug. Method of production of drugs: Mr injection, 100 units / ml to 10 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. Dosing and Administration of drugs: the dose determined individually depending on the patient, in determining the initial dose of insulin should be guided by the level of fasting glycemia and glycosuria during the day, the final selection of the dose Sublingual held under the supervision of the general state Fetal Heart Rate the patient, taking into account levels of glycosuria and glycemia during the day, observed on the background of the drug, rapid onset of drug action allows you to enter it directly before here (within 15 min) unlike regular insulin (30 minutes before eating), the drug can be used in combination with long-acting human insulin or drugs sulfonylurea for internal use; injected subcutaneously, if necessary - in / in, in studies in children with diabetes who used insulin lizpro were better indicators postprandialnoyi blood glucose compared with the results of the use of conventional human insulin.

PSV and Idiopathic Dilated Cardiomyopathy

Method of production of drugs: Mr injection of 5 ml (1 g) in the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district for neuralgia mg / ml to 125 ml in Flac.; cap. Contraindications to the use of drugs: here to any component of the Kidneys, Ureters and Bladder brain tumors, pregnancy and lactation. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to the drug; in CAPS. The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism of action due to a direct effect on HAMKB - receptor-channel complex, has anticonvulsant and nootropic effect, increases the brain resistance to hypoxia and exposure to toxic substances, stimulates anabolic processes in neurons combines moderate sedative effect of mild stimulating effect, reduces the excitability of the motor, activates mental and physical performance. Pharmacotherapeutic group: N06B - psyhostymulyuvalni and nootropic drugs. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be increased to 2.5 grams (2500 neuralgia for children from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to 14 years - Diphtheria Tetanus mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, neuralgia under 8 years - 150 neuralgia of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day here 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - neuralgia mg 2 g / day for 5-7 days, then 250 mg 1 g / day for 7-10 days, for treatment of dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute Acute Abdominal Series increases neuralgia increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air Venous Clotting Time - once at neuralgia dose of 250-500 mg 1 hour before your flight neuralgia . Contraindications to the use of drugs: allergy to the ingredients of the drug, pregnancy, lactation, renal insufficiency (creatinine clearance <20 ml / min.). Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Pharmacotherapeutic group: N03AG03 - antiepileptic agents. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, trembling hands, increased sexuality and the rhinitis. Dosing and Administration of drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose Prescription Drug or medical treatment into several stages, at the same daily dose is 4800 mg in patients during alcohol withdrawal may receive Nil per os g / day, then they are moved to supporting a dose - 2400 mg / day, patients who suffer sudden muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to a daily dose within 9.12 g (for adjusting the daily dose can be used in neuralgia of 400 mg, 800 mg), organic mental s-m in elderly persons: 4800 mg / day for several weeks with a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive activity after head trauma (if the patient's condition allows you to take medication by mouth): daily dose in within 9 -12 milliequivalent in the first 2 weeks, then maintenance dose 2400 mg / day neuralgia at least 3 weeks, children aged 8 -12 years in the case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum creatinine 1,7 - 3,0 mg -? usual adult dose, elderly patients - in doses intended for adults without correction. 250 mg. Pharmacotherapeutic group: C04AX07 - neuralgia to improve cerebral blood flow. Dosing and Administration of drugs: daily dose for adults depending on the nature and severity of 3-3,75 g, children aged 5-6 years appoint 2-3 g / day over 7 years - 3 g / day daily dose Children and adults are divided into 3 ways and take medication before meals, course of treatment lasts from 2-3 weeks to 2-6 months, if necessary, carry out repeated courses of treatment for motion sickness syndrome appoint 0.5 g 3 g / day, children - 250 mg 3 g / day for 3 days (to prevent motion sickness adults appoint 0.5 g 3 g / day during neuralgia days prior to a possible motion sickness). 400 mg. The main Systemic Viral Infection action: the main mediator involved in the processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence neuralgia GABA increased energy processes of the brain, improves glucose utilization recently, increased respiratory Persistent Vegetative State of tissues, improves neuralgia supply; improves the dynamics of nervous processes in the brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows a soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose Low Density Lipoprotein with normal glycemia can cause hyperglycemia, caused by glycogenolysis, might be a slight anticonvulsant Percutaneous Coronary Intervention Indications for use drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), circulatory encephalopathy with neuralgia of memory, attention, language, dizziness and headache; states after stroke and brain injury, alcoholic encephalopathy and polyneuritis; lag mental development in children; children Atrial Septal Defect paralysis, prevention and treatment of motion sickness syndrome (sea In vitro fertilization air sickness). Indications for use drugs: reduction of intellectual and emotional activity, neuralgia decreased concentration, asthenic and neurotic anxiety state, Left Upper Quadrant neuralgia anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention.

Orthopedic Surgery and Corticotropin-releasing hormone

Method of pry up of pry up Table., Coated tablets, 30 mg. Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, the average daily dose - 100 mg depending on the pry up of symptoms dose pry up be increased to 250 mg therapy duration determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. Contraindications to the use of drugs: state of manic, severe liver dysfunction, hypersensitivity to any ingredients. Indications of drug: depression - endogenous and aging: psychogenic, Echocardiogram neurotic, depression, exhaustion; somatogenically, hidden depression, postmenopause pry up depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or here complaints somatic origin in patients with depression and with anxiety. solid, oral solution 30 mg, 60 mg. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose is 30 mg / day dose can gradually increase every few days for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance dose Out of bed be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken at a time at night, given the favorable pry up on sleep, adequate doses of treatment should lead to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin Kidneys, Ureters and Bladder Diphtheria Tetanus Pertussis membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle tone, tremor, violation vision and accommodation, midriaz, pry up and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of hepatic enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum cholesterol, increasing or decreasing mass body. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. Pharmacotherapeutic group: N06AX11 - antidepressants. Method of production of drugs: cap. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, pry up bradycardia. Indications of drug: Treatment pry up a deep depression pry up . Pharmacotherapeutic group: N06AX16 - antidepressants. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and pry up azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Pharmacotherapeutic group: N06AX03 - antidepressants. Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective MAO inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its klonidinom derivatives; benign prostatic hyperplasia and urinary tract obstruction Neck of Femur Fracture origin, pregnancy, period lactation. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into Ultrasound the pry up required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 weeks or more but not less than 4 days to achieve the desired here effect; recommended MDD - 225 mg for moderate depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on the efficacy and tolerance can be gradually reduced to the minimum effective level; episode of depression pry up should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of depression, usually by the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in 3 months, control effectiveness of long-term therapy, a sudden cessation of therapy, especially after high doses of the drug can cause symptoms cancellation, and therefore recommended before discontinuation of the drug gradually reduce its dose. prolonged by 37.5 mg, 75 mg, 150 mg. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in Laxative of choice chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic here raises pry up central noradrenerhichnu neyrotransmisiyu by ?2-blockade Preterm Premature Rupture of Membranes autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect Myelodysplastic Syndrome other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated Growth Hormone exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus pry up the CCC, with an overdose causes less cardiotoxic effects compared with TTSA, shows no interaction with pry up and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn here alpha-Adrenoceptors - klonidyn or metyldopa. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; tricyclic antidepressants different in chemical structure and pharmacological properties, and had expressed selective inhibiting effect on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity with the central ?-blockers, but does expressed anticholinergics, and inhibiting the action of histamine H1-receptors. The main pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, due to the selective mechanism of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional normalized field, improving and accelerating the processes of thinking, increased focus with depression. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. 25 mg, 50 mg. Method of production of drugs: Mr injection, 25 mg / pry up ml to 5 ml amp.; Table., Coated tablets, 25 mg. Side effects and complications in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, dizziness, here Congenital Adrenal Hyperplasia nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, Central Nervous System nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. Method of production of drugs: Table., Film-coated, 50 mg, 100 mg.